SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 291 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 1.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $4,000 | 0.0% | 108 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $4,000 | 0.0% | 108 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $4,000 | -20.0% | 108 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $5,000 | -16.7% | 108 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $6,000 | -50.0% | 108 | -57.3% | 0.00% | -33.3% |
| Q1 2018 | $12,000 | +20.0% | 253 | -0.8% | 0.00% | +50.0% |
| Q4 2017 | $10,000 | +42.9% | 255 | +50.9% | 0.00% | +100.0% |
| Q3 2017 | $7,000 | -53.3% | 169 | -52.1% | 0.00% | -66.7% |
| Q2 2017 | $15,000 | +50.0% | 353 | +12.1% | 0.00% | +50.0% |
| Q1 2017 | $10,000 | +11.1% | 315 | -11.3% | 0.00% | 0.0% |
| Q4 2016 | $9,000 | -25.0% | 355 | -27.7% | 0.00% | -33.3% |
| Q3 2016 | $12,000 | 0.0% | 491 | -16.5% | 0.00% | -25.0% |
| Q2 2016 | $12,000 | – | 588 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |